FindTrial
Sign In

Evaluation of the effect of vitamin B6 on blood cells count in patients using linezolid

Evaluation of the effect of vitamin B6 compared to placebo on the change of blood cells count in patients with chronic osteomyelitis using linezolid

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150721023282N13
Enrollment
70
Registered
2020-08-20
Start date
2020-07-22
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drug-induced pancytopenia. Other drug-induced pancytopenia

Interventions

Intervention 1: Intervention group: Vitamin B6 tablet (manufactured by Iran Hormone Company), 40 mg, twice daily, for 14 days. Intervention 2: Control group: Placebo tablet (manufactured by Isfahan Fa

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Manifestation with chronic osteomyelitis Use of linezolid

Exclusion criteria

Exclusion criteria: Serum level of Hgb less than 8 g/dL WBC count less than 4500 cells/mm3 Platelet count less than 50000 cells/mm3

Design outcomes

Primary

MeasureTime frame
White blood cell count. Timepoint: Before the intervention, the end of weeks 1, 2, and 3 of intervention. Method of measurement: Flow cytometry.;Serum level of hemoglobin. Timepoint: Before the intervention, the end of weeks 1, 2, and 3 of intervention. Method of measurement: Flow cytometry.;Blood platelet count. Timepoint: Before the intervention, the end of weeks 1, 2, and 3 of intervention. Method of measurement: Flow cytometry.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKiana Shirani

Esfahan University of Medical Sciences

kianashirani@med.mui.ac.ir+98 31 3792 7067

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026